PTPN1 and type 2 diabetes mellitus: Although only a few studies of the pharmacological potential of the isorhamnetin-7-O-pentose have been reported, the flavonoid shows a great therapeutic potential for type 2 diabetes by down-regulating the protein tyrosine phosphatase-1B (PTP1B) expression [65].